Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.

Authors:
Vincenzo Bruzzese
Vincenzo Bruzzese
"Nuovo Regina Margherita" Hospital
Italy

J Clin Rheumatol 2012 Dec;18(8):413-5

Internal Medicine and Rheumatology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.

We report the case of a patient with a simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. This condition differs from both the PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis) syndrome, in which arthritis is absent, and the PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome, in which suppurative hidradenitis is lacking. Our patient failed to respond to etanercept therapy, whereas all dermatologic and rheumatic manifestations completely regressed following infliximab infusion. We therefore propose that simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and seronegative spondyloarthritis might represent a distinct syndrome that could be termed the PASS syndrome. Tumor necrosis factor α therapies seem to play selective roles.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0b013e318278b84cDOI Listing
December 2012
13 Reads

Publication Analysis

Top Keywords

gangrenosum acne
20
suppurative hidradenitis
20
pyoderma gangrenosum
20
conglobata suppurative
12
acne conglobata
12
axial spondyloarthritis
8
presence pyoderma
8
simultaneous presence
8
hidradenitis axial
8
necrosis factor
8
suppurative
5
acne
5
hidradenitis
5
pyoderma
5
etanercept therapy
4
therapy dermatologic
4
respond etanercept
4
rheumatic manifestations
4
manifestations completely
4
dermatologic rheumatic
4

Similar Publications